Although there have been some discrepancies reported between studies, there is consensus that NAT1 inhibition or NAT1 KO in cultured breast cancer cells results in cell growth retardation and reduced migration/invasion [14,15,16,17,18,19,20]. Here, NAT1 is linked to breast carcinoma.